Citi Trends Inc: Form 10-Q for the period ended Oct 31, 2020
Filed with the SEC on Dec 8, 2020 and accepted by EDGAR at Dec 8, 2020, 07:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-08-02 to 2020-10-31 | $199.1m | us-gaap:Revenues |
| Revenue | 9 months2020-02-02 to 2020-10-31 | $531.4m | us-gaap:Revenues |
| Selling, general and administrative | 3 months2020-08-02 to 2020-10-31 | $69.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-02-02 to 2020-10-31 | $180.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-08-02 to 2020-10-31 | $9.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-02-02 to 2020-10-31 | $8.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-08-02 to 2020-10-31 | $193.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2020-02-02 to 2020-10-31 | $733.0k | us-gaap:InterestExpense |
| Income tax | 3 months2020-08-02 to 2020-10-31 | $2.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-02-02 to 2020-10-31 | $1.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-08-02 to 2020-10-31 | $7.0m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months2020-02-02 to 2020-10-31 | $5.9m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2020-08-02 to 2020-10-31 | $0.67 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-02-02 to 2020-10-31 | $0.57 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-08-02 to 2020-10-31 | $0.67 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-02-02 to 2020-10-31 | $0.57 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-08-02 to 2020-10-31 | 10,401,153 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-02-02 to 2020-10-31 | 10,444,106 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-02-02 to 2020-10-31 | $63.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-02-02 to 2020-10-31 | $11.9m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2020-02-02 to 2020-10-31 | $831.0k | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2020-02-02 to 2020-10-31 | $16.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2020-10-31 | $229.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-10-31 | $481.9m | us-gaap:Assets |
| Current liabilities | At period end2020-10-31 | $170.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-10-31 | $321.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-10-31 | $160.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-20-014239. Last ingested by Listed: Oct 27, 2026, 17:26 ET. Listed shows no prices and gives no investment advice.